AN 8-WEEK, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, FIXED-DOSE EFFICACY AND SAFETY TRIAL OF ASENAPINE IN ADOLESCENT SUBJECTS WITH SCHIZOPHRENIA

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: cc585556958fc613cfd46f8bfaec91a700ed9025
First added on: Apr 16, 2025